CM
FMI

Castleark Management’s Foundation Medicine, Inc. FMI Stock Holding History

Castleark Management’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,540
Closed -$1.33M – 461
2017
Q4 		$1.33M Buy
+19,540
New +$1.01M 0.04% 273

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Castleark Management's FMI Position: Q1 2018 in Review

Castleark Management sold out of Foundation Medicine, Inc. (FMI) in Q1 2018, closing a stake of 19,540 shares — an estimated $1.33M sold.

Castleark Management first reported a position in FMI in Q4 2017 and held it in 1 quarter. The position peaked at $1.33M in Q4 2017. 144 funds tracked by Wall St. Rank hold FMI as of Q1 2018.

  • Castleark Management reported no remaining Foundation Medicine, Inc. position as of Q1 2018 after selling out during the quarter.
  • Castleark Management sold 19,540 Foundation Medicine, Inc. shares in Q1 2018, an estimated $1.33M.
  • Castleark Management first reported a position in Foundation Medicine, Inc. in Q4 2017 and held it in 1 quarter.
  • Castleark Management's Foundation Medicine, Inc. position peaked at $1.33M in Q4 2017.
  • 144 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2018.

Based on Castleark Management's 13F filing for Q1 2018, filed 15 May 2018.